PLAY PODCASTS
Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms

Breakthroughs in Multiple Myeloma Treatment and Von Willebrand Disease Mechanisms

Blood Podcast

October 23, 202524m 11s

Audio is streamed directly from the publisher (prfx.byspotify.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this week's episode of the Blood Podcast, Associate Editor Dr. James Griffin interviews Drs. Binod Dhakal and Ruben Bierings about their respective papers published in this week's issue of Blood. Dr. Dhakal presents his study on using talquetamab, a bispecific antibody, as a bridging therapy before BCMA-targeted CAR T-cell therapy in multiple myeloma patients, showing promising results with high response rates and manageable toxicities. Next, Dr. Bierings identified patients with genetic variants in the guanine exchange factor MAP kinase–activating death domain (MADD) that impair VWF secretion from endothelial cells and possibly cause VWD type 1. 

Featured Articles

Topics

hematologyoncologymedicalmedical researchlymphomaleukemiaCAR Tred cells